Kezar Life Sciences, Inc. (KZR)

NASDAQ: KZR · IEX Real-Time Price · USD

0.801

-0.025 (-2.98%)

At close: Apr 24, 2024, 4:00 PM

0.790

-0.011 (-1.42%)

After-hours: Apr 24, 2024, 7:37 PM EDT

Kezar Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-101.87	-68.24	-54.63	-41.74	-35.09	-23.17	-8.52	-8.99
Depreciation & Amortization	1.07	1.02	1.51	1.54	1.3	0.69	0.18	0.15
Share-Based Compensation	18.14	14.01	7.6	4.94	4.01	1.99	0.2	0.13
Other Operating Activities	1.02	-5.64	3.09	-1.69	-0.1	-0.31	0.03	-1.05
Operating Cash Flow	-81.65	-58.85	-42.44	-36.95	-29.88	-20.79	-8.11	-9.76
Capital Expenditures	-1.81	-1.58	-0.32	-0.19	-0.61	-1.11	-0.39	-0.13
Change in Investments	77.85	-89.81	-28.13	-56.3	21.03	-82.79	0	0
Investing Cash Flow	76.05	-91.39	-28.44	-56.5	20.42	-83.9	-0.39	-0.13
Share Issuance / Repurchase	0.64	127.86	103.05	99.64	0.27	77.91	0	0.04
Debt Issued / Paid	0	0	9.53	0	0	0	0	0
Other Financing Activities	-	-	-	-	-	-	49.76	-
Financing Cash Flow	0.64	127.86	112.59	99.64	0.27	77.91	49.76	0.04
Exchange Rate Effect	-0	-0.05	-0.05	0.08	-0.05	-0.08	0.03	-0.15
Net Cash Flow	-4.96	-22.43	41.65	6.28	-9.23	-26.86	41.29	-10.01
Free Cash Flow	-83.45	-60.42	-42.75	-37.14	-30.48	-21.9	-8.5	-9.89
Free Cash Flow Margin	-1192.14%	-	-	-	-	-	-	-
Free Cash Flow Per Share	-1.15	-0.90	-0.81	-0.84	-1.60	-2.13	-14.18	-29.23

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).